When opportunity met aspirational goals: accelerator MS, microdosing and absolute bioavailability studies
Could traditional mass-balance studies in the ‘twilight zone’ be improved by means of accelerator MS measurements?
News & Analysis
European Bioanalysis Forum recommendation on biomarker bioanalysis published in Bioanalysis
Collaboration exploring the use of LC–MS/MS in microdosing trials
GlaxoSmithKline to acquire Human Genome Sciences at the second time of asking
Mimicking whole-body physiology: multiple organ-on-chip systems
EPO–Fc: developing detection tests for an emerging doping agent
Conference Report: 3rd Annual Symposium of Chemical and Pharmaceutical Structure Analysis
Research Spotlight: Measurement and validation of cell-based assays with microfluidics at the National Institute of Standards and Technology
Overcoming bioanalytical challenges in an Onglyza® intravenous [14C]microdose absolute bioavailability study with accelerator MS
Applications of accelerator MS in pediatric drug evaluation
European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development
Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites
In silico prediction for the investigation of comedication interferences in quantitative LC–MS detection in the SRM mode
Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management
Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications
Acknowledgements